PUBLIC HEALTH: Provides relative to peptides. (8/1/26)

The bill header was updated to reflect the 'Original' status with a new bill number (SLS 26RS-509) and session date, replacing the 'Enrolled' version.

The footer and digest sections were restructured to match the standard format for an original bill draft, including a disclaimer about the digest's non-binding nature.

The text was edited to remove specific references to 'state permitted pharmacies' and 'Louisiana licensed pharmacists,' shifting the focus to general licensing boards and provider responsibilities.

The list of acceptable peptide sources was simplified by removing the specific citation of 'United States Pharmacopeia - National Formulary chapters' and consolidating the description of 503A pharmacies.

A new explicit requirement was added mandating that prescribing providers must verify that prescribed peptides are not on the FDA's prohibited compounding list.

Added co-sponsors (Representatives Bayham, Berault, Carver, and Wyble) and official signatures (President of the Senate, Speaker of the House, and Governor), indicating the bill has been fully approved and is ready for execution.

Removed the Senate Legislative Services digest and committee amendment history, as these are procedural documents no longer needed in the final enrolled version.

Changed the header from 'REENGROSSED' to 'ENROLLED' to reflect the bill's final status.

Added a new provision allowing licensed pharmacists in state-permitted pharmacies to compound and dispense peptides, provided they comply with 21 U.S.C. 353a and USP-NF chapters.

Updated the source requirements for peptides to specify that they must come from either a 503B outsourcing facility complying with 21 U.S.C. 353b or a 503A compounding pharmacy complying with 21 U.S.C. 353a and USP-NF chapters.

Changed the requirement for prescribing providers to ensure peptides are prepared in accordance with the specific federal and national standards mentioned above, rather than just checking against a prohibited list.